Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Regina Deja
Observed names:
R Deja,
R. Deja
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0002-2560-4893
Observed ORCID:
0000-0002-2560-4893
OpenAlex ID:
A5091650525
Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer
2009
·
Monika Pietrowska
, Lukasz Marczak
, et al.
·
Journal of Translational Medicine
·
75
PDF
Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
2019
·
Rafał Suwinski
, Monika Giglok
, et al.
·
BMC Cancer
·
40
PDF
[Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
2009
·
Aleksandra Chmura
, Andrzej Wojcieszek
, et al.
·
PubMed
·
12
[Evaluation of selected serum protein markers as early detectors of ovarian cancer].
2008
·
Jolanta Mrochem
, Krzysztof Sodowski
, et al.
·
PubMed
·
12
The Association between Echocardiographic Parameters of Heart Failure with Preserved Ejection Fraction and Fluid Status Biomarkers in Hemodialysis Patients
2024
·
Mariusz Lupa
, Agnieszka Pardała
, et al.
·
Diagnostics
·
5
Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer
2024
·
Beata Smolska-Ciszewska
, Jolanta Mrochem-Kwarciak
, et al.
·
Radiotherapy and Oncology
·
4
PDF
Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer
2023
·
Seweryn Gałecki
, Agnieszka Gdowicz-Kłosok
, et al.
·
Cells
·
4
PDF
Early diagnosis of radiotherapy failure for patients with head and neck cancer: the role of biochemical markers
2017
·
Jolanta Mrochem-Kwarciak
, Tomasz Rutkowski
, et al.
·
Tumori Journal
·
4
[Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy].
2011
·
Jolanta Mrochem-Kwarciak
, Izolda Mrochen-Domin
, et al.
·
PubMed
·
4
The Prognostic Value of Osteopontin (OPN) and Hemoglobin (Hb) Levels in Patients with Head and Neck Cancer Treated With Radiation Therapy
2017
·
J.J. Mrochem-Kwarciak
, T. Rutkowski
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
CYFRA 21-1 as an Instant Prognostic Marker of Tumor Response on Radiation With or Without Chemotherapy in Patients With Larynx and Hypopharynx Squamous Cell Carcinoma
2016
·
J.J. Mrochem-Kwarciak
, T. Rutkowski
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
CYFRA 21-1 as a Prognostic Marker of Tumor Response to Radiation Alone or Combined With Chemotherapy in Patients With Carcinoma of Larynx or Hypopharynx
2015
·
Jolanta Mrochem‐Kwarciak
, T. Rutkowski
, et al.
·
International Journal of New Technology and Research
·
1
Użyteczność aparatu CellaVision TM DM8 w ocenie obrazu wzoru odsetkowego krwinek białych u pacjentów onkologicznych
2010
·
Barbara Masłyk
, Regina Deja
, et al.
·
Diagnostyka Laboratoryjna
·
1
Associations Between OPN-CD44 Axis Genetic Variability, Plasma Osteopontin, and Treatment Outcomes in Head and Neck Squamous Cell Carcinoma
2026
·
Agnieszka Gdowicz-Kłosok
, Regina Deja
, et al.
·
International Journal of Molecular Sciences
PDF
P-12 Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
2021
·
Jolanta Mrochem-Kwarciak
, Andrzej Wygoda
, et al.
·
Oral Oncology
P-46 Prognostic value of inflammatory markers in HPV-positive and HPV-negative patients with oropharyngeal cancer (OPC)
2021
·
Jolanta Mrochem-Kwarciak
, Tomasz Rutkowski
, et al.
·
Oral Oncology
P-45 Assessment of clinical utility of angiogenesis and hypoxia markers in patients with head and neck cancer (HNC)
2021
·
Jolanta Mrochem-Kwarciak
, Andrzej Wygoda
, et al.
·
Oral Oncology
P-11 Assessment of clinical utility of angiogenesis and hypoxia markers in patients with head and neck cancer (HNC)
2021
·
Jolanta Mrochem-Kwarciak
, Andrzej Wygoda
, et al.
·
Oral Oncology
Prognostic Value of Erythropoietin (Epo), Soluble Erythropoietin Receptor (sEpoR) and Hematological Parameters in Patients with Head and Neck Cancer (HNC) Treated with Radio- or Radio-Chemotherapy.
2019
·
J.J. Mrochem-Kwarciak
, T. Rutkowski
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Prognostic value of erythropoietin (EPO), soluble erythropoietin receptor (SEPOR) and hematological parameters in patients with head and neck cancer treated (HNC) with radio- or radio-chemotherapy
2019
·
J. Mrochem-Kwaciak
, A. Wygoda
, et al.
·
Clinica Chimica Acta
Prognostic Value of Reticulocyte, Immature Reticulocyte, and Osteopontin in HNSCC Patients Treated by Radiation And Chemotherapy
2018
·
J.J. Mrochem-Kwarciak
, T. Rutkowski
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
PO-101: Osteopontin (OPN) as an instant, predictive marker of tumour hypoxia in head and neck cancer patients
2017
·
J. Mrochem-Kwarciak
, T. Rutkowski
, et al.
·
Radiotherapy and Oncology
Prognostyczne znaczenie stężenia osteopontyny (OPN) i hemoglobiny (Hb) u chorych na raka regionu głowy i szyi (RRGiSz) poddanych radio i radiochemioterapii
2017
·
Jolanta Mrochem‐Kwarciak
, T. Rutkowski
, et al.
·
Diagnostyka Laboratoryjna
[Nr 77] Parametry morfologii krwi jako czynniki prognostyczne w niedrobnokomórkowym raku płuca
2013
·
Barbara Masłyk
, Monika Giglok
, et al.
·
Zeszyty Naukowe WCO Letters in Oncology Science
[Nr 54] Prognostyczne znaczenie osteopontyny u chorych na płaskonabłonkowego raka regionu głowy i szyi
2013
·
Jolanta Mrochem-Kwarciak
, Tomasz Rutkowski
, et al.
·
Zeszyty Naukowe WCO Letters in Oncology Science
Show more works
View as search
Works count:
35
Citation count:
164
H-index:
5
I10-index:
4
Year
Topic
Type